CMS Reevaluates Accelerated Payment Program And Suspends Advance Payment Program

Published in Member Communities on April 27, 2020

An Accelerated/Advance Payment is intended to provide necessary funds when there is an interruption in claim submission. The expedited payments are offered in circumstances including natural disasters or national emergences, such as the COVID-19 pandemic. The temporary loan programs are available to both Part A and Part B providers/suppliers as resource to assist with cash flow disruptions.  
 
Effective April 26th, 2020, CMS will not be accepting any new applications for the Advance Payment Program and will be reevaluating all pending and new applications for the Accelerated Payment Program. Currently, suspension for the Advance Payment Program applies to Part B suppliers.
 
According to the release by CMS, “Since expanding the programs on March 28, 2020, CMS approved over 21,000 applications totaling $59.6 billion in payments to Part A providers, which includes hospitals. For Part B suppliers, including doctors, non-physician practitioners and durable medical equipment suppliers, CMS approved almost 24,000 applications advancing $40.4 billion in payments.”

While the Advance Payment Program may be suspended for suppliers, there are still other opportunities available for funding. Stay tuned for further updates. For any questions related to the Accelerated/Advance Payment Program, please reach out to Ronda Buhrmester at ronda.buhrmester@vgm.com or via phone/text at 217-493-5440.

From Our Experts

Introducing the F&P Nova Nasal in the United States thumbnail Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea. Introducing the F&P Nova Nasal in the United States thumbnail Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea. A Note from the President: VGM is Evolving For You thumbnail A Note from the President: VGM is Evolving For You VGM is evolving with purpose by investing in advocacy, technology, and services to support HME providers through industry change and ensure long-term viability. Member Spotlight: Browning's Pharmacy and Health Care thumbnail Member Spotlight: Browning's Pharmacy and Health Care Browning's Pharmacy and Health Care: Longtime VGM HME provider since 1987, delivering quality home medical equipment, pharmacy services, and patient support. Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard thumbnail Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard Discover how integrated sleep programs help providers cut OSA screening-to-treatment timelines to 30 days while improving patient outcomes. Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard thumbnail Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard Discover how integrated sleep programs help providers cut OSA screening-to-treatment timelines to 30 days while improving patient outcomes. 2026 HME Woman of the Year Award Nominations Open Now thumbnail 2026 HME Woman of the Year Award Nominations Open Now Submit nominations for the 2026 HME Woman of the Year Award. Recognize top women leaders in HME, DME, and CRT. Winner announced at Heartland Conference 2026. Improving Efficiency Through Insight and Industry Connection thumbnail Improving Efficiency Through Insight and Industry Connection Spring is right around the corner, and here in the "deep-Midwest," it cannot come soon enough. That said, we are not interested in wishing time away. There is still a lot that can be done with the limited time we have.